Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	103131
Country	China

Received	2024-11-10 14:52
Peer-Review Started	2024-11-10 14:52
To Make the First Decision
Return for Revision	2024-12-23 00:09
Revised	2025-01-02 01:46
Second Decision	2025-02-18 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-02-18 08:23
Articles in Press	2025-02-18 08:23
Publication Fee Transferred	2025-01-09 14:03
Edit the Manuscript by Language Editor	2025-02-24 10:51
Typeset the Manuscript	2025-03-07 07:25
Publish the Manuscript Online	2025-03-25 16:19

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Chemistry, Medicinal
Manuscript Type	Clinical Trials Study
Article Title	Intraperitoneal perfusion of endostatin improves the effectiveness and prolongs the prognosis of patients with gastric cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Yong Liu, Hong-Gen Liu and Cheng Zhao
ORCID	Author(s) ORCID Number Yong Liu http://orcid.org/0009-0001-6520-3402 Cheng Zhao http://orcid.org/0009-0003-6692-4679
Funding Agency and Grant Number	Funding Agency Grant Number Scientific Research Project of Tianjin Municipal Education Commission 2018KJ015
Corresponding Author	Cheng Zhao, Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No. 88 Changling Road, Xiqing District, Tianjin 300000, China. chengzi0845_cn@sina.com
Key Words	Gastric cancer; Recombinant human endostatin; Peritoneal metastasis; Malignant ascites; Cisplatin; Efficacy; Prognosis
Core Tip	Recombinant human endostatin (RH-endostatin) is an angiogenesis-inhibiting drug; the present study demonstrates that the intraperitoneal perfusion of RH-endostatin prolongs the prognosis of patients with gastric cancer (GC) with malignant ascites, particularly in patients with small and moderate ascites volumes. Intraperitoneal RH-endostatin perfusion significantly improve the quality of life in patients with GC with ascites, with less toxicity.
Publish Date	2025-03-25 16:19
Citation	<p>Liu Y, Liu HG, Zhao C. Intraperitoneal perfusion of endostatin improves the effectiveness and prolongs the prognosis of patients with gastric cancer. <i>World J Gastrointest Oncol</i> 2025; 17(4): 103131</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i4/103131.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i4.103131

Full Article (PDF)	WJGO-17-103131-with-cover.pdf
CONSORT 2010 Statement	103131-CONSORT-2010-statement.pdf
Manuscript File	103131_Auto_Edited_090924.docx
Answering Reviewers	103131-answering-reviewers.pdf
Audio Core Tip	103131-audio.m4a
Biostatistics Review Certificate	103131-biostatistics-statement.pdf
Clinical Trial Registration Statement	103131-clinical-trial-registration-statement.pdf
Conflict-of-Interest Disclosure Form	103131-conflict-of-interest-statement.pdf
Copyright License Agreement	103131-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	103131-foundation-statement.pdf
Signed Informed Consent Form(s) or Document(s)	103131-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document	103131-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate	103131-non-native-speakers.pdf
Peer-review Report	103131-peer-reviews.pdf
Scientific Misconduct Check	103131-scientific-misconduct-check.png
Scientific Editor Work List	103131-scientific-editor-work-list.pdf
CrossCheck Report	103131-crosscheck-report.pdf